Table 3 Comparison between GS 6 disease and more aggressive disease in PCa patients

N, 15 (23.8%)

N, 48 (76.2%)

–

Age, yr

73.0 (9.0)

72.0 (12.0)

0.520

tPSA, ng/mL

7.47 (4.6)

9.75 (23.6)

0.156

fPSA

0.97 (0.6)

1.13 (1.7)

0.358

%fPSA

13.08 (8.0)

10.98 (9.2)

0.302

p2PSA, pg/mL

13.9 (13.4)

45.3 (72.6)

0.001

%p2PSA

1.26 (1.0)

3.17 (2.2)

< 0.001

PHI

35.4 (28.0)

120.8 (148.6)

< 0.001

Positive core number

3.0 (4.0)

6.0 (6.0)

0.032